Search EN menu en EIB GROUP CLIENT PORTAL
Close EIB GROUP CLIENT PORTAL
Search
Search
Results
Top 5 search results See all results Advanced search
Top searches
    Most visited pages

        GHANA VACCINES CONSORTIUM

        Signature(s)

        Amount (.*)
        € 5,000,000
        Sector(s)
        Industry : € 5,000,000
        Signature date(s)
        29/03/2023 : € 5,000,000
        (*) Including a € 5,000,000 Investment Grants provided by the EU-AFRICA INFRASTRUCTURE TRUST FUND

        Summary sheet

        Release date
        13 April 2023
        Status
        Reference
        Signed | 29/03/2023
        20220170
        Project name
        Promoter - financial intermediary
        GHANA VACCINES CONSORTIUM
        DEK VACCINES LTD
        Proposed EIB finance (Approximate amount)
        Total cost (Approximate amount)
        EUR 5 million
        EUR 47 million
        Location
        Sector(s)
        Description
        Objectives

        The project consists in a grant facility of up to EUR 5m providing seed financing to support the construction, furnishing and validation of a fill and finish vaccine manufacturing facility in the suburbs of Accra, Ghana.

        The facility will initially target vaccines that are a priority for the African continent and is expected to contribute to enhanced regional independence in health security.

        Environmental aspects
        Procurement

        The promoter is required to implement the project in accordance with the EIB's Environmental and Social Policy and Standards.

        The promoter is required to implement the project in accordance with the EIB's Guide to Procurement.

        Milestone
        Under appraisal
        Approved
        Signed
        27 March 2023
        29 March 2023
        Related projects
        Parent project
        COVID-19 ESSENTIAL API MANUFACTURING IN AFRICA

        Disclaimer

        Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
        They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

        General enquiries and comments

        The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
        Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
        Alternatively, the EIB can be contacted through its external offices.
        Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

        Media enquiries

        Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

        Complaints mechanism

        Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

        Zero tolerance against fraud and corruption

        The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

        Related publications